Thus, NXN emerges as a candidate gene that needs to be further studied to address its ability to determine not only the temporal sequence of neurogenesis but simultaneously the differences in the AD brain due to Aβ peptide deposition. This evidence concerns the gene NXN and Alzheimer disease.